KALARIS THERAPEUTICS INC
KLRS·482929106·US·Common Stock·Healthcare - Biotechnology-Activist
KLRS (KALARIS THERAPEUTICS INC) is held by 31 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($7.5M), Alyeska Investment Group, L.P. ($3.3M), VANGUARD CAPITAL MANAGEMENT LLC ($1.5M). Net institutional sentiment: Bullish.
31
Holders
Avg rating(5 Elite)
$17.7M
Total Value
69% (36)
Fund Consensus
22 buying - 10 selling
Who's Trading
ActivistSBSamsara BioCapital, L.P.44.8%May 22, 2026
InsiderHRHagen Brett RSell $13KMar 20, 2026
ActivistIPInvus Public Equities, L.P.1.5%Jul 29, 2025
ActivistECEcoR1 Capital, LLC1.1%May 15, 2025
InsiderHRHagen Brett RSell $8KMar 26, 2025
ActivistGSGILEAD SCIENCES, INC.3.9%Mar 20, 2025
13F: Insider & Congress:
Showing 1-20 of 36
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer